All Stories

  1. Antidepressants interact with an LPA3 receptor binding site: Functional and docking studies
  2. Multiple LPA3 Receptor Agonist Binding Sites Evidenced Under Docking and Functional Studies
  3. Antidepressants interact with an LPA3receptor binding site: functional and docking studies
  4. LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites
  5. LPA3: Pharmacodynamic differences between lysophosphatidic acid and oleoyl-methoxy glycerophosphothionate. Biased agonism, two sites
  6. Multiple LPA3 receptor agonist binding sites evidenced under docking and functional studies
  7. Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites
  8. LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization
  9. Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites
  10. LPA3 Receptor Phosphorylation Sites: Roles in Signaling and Internalization
  11. Roles of the α1B-Adrenergic Receptor Phosphorylation Domains in Signaling and Internalization
  12. Lysophosphatidic acid receptor LPA1 trafficking and interaction with Rab proteins, as evidenced by Förster resonance energy transfer
  13. Cell Trafficking and Function of G Protein-coupled Receptors
  14. Mutation of putative phosphorylation sites in the free fatty acid receptor 1: Effects on signaling, receptor phosphorylation, and internalization
  15. Roles of Receptor Phosphorylation and Rab Proteins in G Protein-Coupled Receptor Function and Trafficking
  16. The LPA3 Receptor: Regulation and Activation of Signaling Pathways
  17. Updates in the function and regulation of α1‐adrenoceptors
  18. Distinct phosphorylation sites/clusters in the carboxyl terminus regulate α1D-adrenergic receptor subcellular localization and signaling
  19. S1P1 receptor phosphorylation, internalization, and interaction with Rab proteins: effects of sphingosine 1-phosphate, FTY720-P, phorbol esters, and paroxetine
  20. Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization
  21. Novel Structural Approaches to Study GPCR Regulation
  22. A Latin American Perspective on G Protein–Coupled Receptors
  23. α1B-Adrenergic Receptors Differentially Associate with Rab Proteins during Homologous and Heterologous Desensitization
  24. Visualizing G Protein-coupled Receptors in Action through Confocal Microscopy Techniques
  25. Isoforms of protein kinase C involved in phorbol ester-induced sphingosine 1-phosphate receptor 1 phosphorylation and desensitization
  26. Conventional protein kinase C isoforms mediate phorbol ester-induced lysophosphatidic acid LPA1 receptor phosphorylation
  27. Free fatty acids and protein kinase C activation induce GPR120 (free fatty acid receptor 4) phosphorylation
  28. Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
  29. Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions
  30. Roles of phosphoinositide-dependent kinase-1 in α1B-adrenoceptor phosphorylation and desensitization
  31. EGF and angiotensin II modulate lysophosphatidic acid LPA1 receptor function and phosphorylation state
  32. Mechanisms involved in α1B-adrenoceptor desensitization
  33. Dissecting how receptor tyrosine kinases modulate G protein-coupled receptor function
  34. Roles of the α1A-adrenergic receptor carboxyl tail in protein kinase C-induced phosphorylation and desensitization
  35. α1D-Adrenergic Receptors
  36. Receptor tyrosine kinases regulate α1D-adrenoceptor signaling properties: Phosphorylation and desensitization
  37. Signaling properties of human α1D-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization
  38. Effect of inhibitors of mitogen-activated protein kinase kinase on α1B-adrenoceptor phosphorylation
  39. G Protein-Coupled Receptor-Receptor Tyrosine Kinase Receptor Crosstalk: Regulation of Receptor Sensitivity and Roles of Autocrine Feedback Loops and Signal Integration
  40. Regulation of LPA receptor function by estrogens
  41. Phosphorylation, desensitization and internalization of human α1B-adrenoceptors induced by insulin-like growth factor-I
  42. Roles of c-Src in α1B-adrenoceptor phosphorylation and desensitization
  43. Lysophosphatidic acid LPA1 receptor close-up
  44. Editorial: Signal transduction in Mexico
  45. Insulin-Like Growth Factor-I Induces α1B-Adrenergic Receptor Phosphorylation through Gβγ and Epidermal Growth Factor Receptor Transactivation
  46. Role of epidermal growth factor receptor transactivation in α1B-adrenoceptor phosphorylation
  47. Estrogens Cross-Talk to α1b-Adrenergic Receptors
  48. Okadaic acid increases the phosphorylation state of α1A-adrenoceptors and induces receptor desensitization
  49. Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor Receptors
  50. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1
  51. The elusive α1D-adrenoceptor: molecular and cellular characteristics and integrative roles
  52. Insulin induces α1B-adrenergic receptor phosphorylation and desensitization
  53. Human α1D-adrenoceptor phosphorylation and desensitization
  54. Peroxovanadate induces $alpha;1B-adrenoceptor phosphorylation and association with protein kinase C
  55. Lysophosphatidic acid induces $alpha;1B-adrenergic receptor phosphorylation through G$beta;$gamma;, phosphoinositide 3-kinase, protein kinase C and epidermal growth factor receptor transactivation
  56. G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein?protein interactions
  57. α1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-β
  58. Molecular cloning and functional expression of the guinea pig α1a-adrenoceptor
  59. Protein kinase C-α1b-adrenoceptor coimmunoprecipitation: effect of hormones and phorbol myristate acetate
  60. Phosphorylation and desensitization of α1d-adrenergic receptors
  61. Cross-talk between receptors with intrinsic tyrosine kinase activity and α1b-adrenoceptors
  62. Norepinephrine- and Phorbol Ester-induced Phosphorylation of α1a-Adrenergic Receptors
  63. α1-Adrenoceptors: function and phosphorylation
  64. Protein kinase C-mediated phosphorylation and desensitization of human α1b-adrenoceptors
  65. Inverse α1A and α1D adrenoceptor mRNA expression during isolation of hepatocytes
  66. α1-Adrenoceptors
  67. Intracellular Calcium and α1b-Adrenoceptor Phosphorylation
  68. Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing α1d -adrenoceptors
  69. Angiotensin AT1 receptors in Clone 9 rat liver cells: Ca2+ signaling and c-fos expression
  70. Crosstalk: phosphorylation of α1b -adrenoceptors induced through activation of bradykinin B2 receptors
  71. Chloroquine inhibits α1B-adrenergic action in hepatocytes
  72. α1-Adrenoceptor subtype activation increases proto-oncogene mRNA levels. Role of protein kinase C
  73. Activation of Endothelin ETAReceptors Induces Phosphorylation of α1b-Adrenoreceptors in Rat-1 Fibroblasts
  74. Atypical angiotensin II receptors coupled to phosphoinositide turnover/calcium signalling in catfish hepatocytes
  75. Purification and Characterization of Receptors for Activated Protein Kinase C from Rat Hepatocytes
  76. Hormonal Responsiveness of Hepatocytes After Hypothermic Preservation in University of Wisconsin Solution
  77. Characterization of the β2 adrenoceptors of dog liver
  78. Coexpression of α1A- and α1B-adrenoceptors in the liver of the rhesus monkey (Macaca mulatta)
  79. Characterization of the α1-adrenoceptors of cat liver. Predominance of the α1A-adrenergic subtype
  80. Hormonal modulation of c-fos expression in isolated hepatocytes. Effects of angiotensin II and phorbol myristate acetate on transcription and mRNA degradation
  81. Characterization of the human liver α1-adrenoceptors: predominance of the α1A subtype
  82. α1-Adrenoceptor subtype selectivity of tamsulosin: Studies using livers from different species
  83. Protein kinases and phosphatases modulate c-fos expression in rat hepatocytes. effects of angiotensin II and phorbol myristate acetate
  84. Characterization of the α1B-Adrenoceptors of Catfish Hepatocytes: Functional and Binding Studies
  85. Characterization of the α1-adrenoceptors of dog liver: predominance of the α1A-subtype
  86. Glycyl-histidyl-lysine interacts with the angiotensin II AT1 receptor
  87. Inhibition of hormone-stimulated inositol phosphate production and disruption of cytoskeletal structure. Effects of okadaic acid, microcystin, chlorpromazine, W7 and nystatin
  88. Characterization of the hepatic α1B-adrenoceptors of rats, mice and hamsters
  89. Characterization of the α1B-adrenergic receptors of chicken hepatocytes. Signal transduction and actions
  90. α1-adrenergic action: Receptor subtypes, signal transduction and regulation
  91. Hepatocyte homologous β2-adrenergic desensitization is associated with a decrease in number of plasma membrane β2-adrenoceptors
  92. Guinea pig hepatocyte α1A-adrenoceptors: characterization, signal transduction and regulation
  93. Histamine activates phosphorylase and inositol phosphate production in guinea pig hepatocytes
  94. Angiotensin II and active phorbol esters induce proto-oncogene expression in isolated rat hepatocytes
  95. Species heterogeneity of hepatic α1-adrenoceptors: α1A-, α1B- and α1C-subtypes
  96. Modulation by protein kinase C of the hormonal responsiveness of hepatocytes from lean (Fa/fa?) and obese (fa/fa) Zucker rats
  97. Characterization and detoxification of an easily prepared acellular pertussis vaccine. Antigenic role of the A protomer of pertussis toxin
  98. Effect of okadaic acid on hormone- and mastoparan-stimulated phosphoinositide turnover in isolated rat hepatocytes
  99. Differences in phorbol ester-induced decrease of the activity of protein kinase C isozymes in rat hepatocytes
  100. α1-Adrenoceptor subtypes in aorta (α1A) and liver (α1B)
  101. Activation of protein kinase C inhibits hormonal stimulation of the GTPase activity of Gi in human platelets
  102. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes
  103. Contrasting effects of phorbol dibutyrate and phorbol myristate acetate in rabbit aorta
  104. Modulation of glucagon actions by phorbol myristate acetate in isolated hepatocytes. Effect of hypothyroidism
  105. Activation of protein kinase C alters the interaction of α2 -adrenoceptors and the inhibitory GTP-binding protein (Gi ) in human platelets
  106. Beta1-adrenoceptors in rat hepatoma. Desensitization by isoproterenol and phorbol-myristate-acetate
  107. Intercellular communication within the liver has clinical implications
  108. Homologous and heterologous β-adrenergic desensitization in hepatocytes. Additivity and effect of pertussis toxin
  109. ‘Inhibitory’ receptors and ion channel effectors
  110. Multiple species and isoforms of Bordetella pertussis toxin substrates
  111. Effect of phorbol esters on the hormonal responsiveness of isolated white fat cells
  112. Phorbol esters and calcium-mobilizing hormones increase membrane-associated protein kinase C activity in rat hepatocytes
  113. Angiotensin II receptors: one type coupled to two signals or receptor subtypes?
  114. Insulin-like effect of epidermal growth factor in isolated rat hepatocytes
  115. Effect of pertussis toxin on the heart acetylcholine muscarinic receptor affinity
  116. Effect of pertussis toxin on the heart muscarinic-cholinergic receptors and their function
  117. Homologous and heterologous desensitization of one of the pathways of the α1-adrenergic action. Effects of epinephrine, vasopressin, angiotensin II and phorbol 12-myristate 13-acetate
  118. Phorbol esters, vasopressin and angiotensin II block α1-adrenergic action in rat hepatocytes. Possible role of protein kinase C
  119. Possible existence of two mechanisms involved in α1-adrenergic action: Effect of Sgd 101/75
  120. Pertussis toxin effects on adenylate cyclase activity, cyclic AMP accumulation and lipolysis in adipocytes from hypothyroid, euthyroid and hyperthyroid rats
  121. Effects of [1-Nα-trinitrophenylhistidine, 12-homoarginine]glucagon on cyclic AMP levels and free fatty acid release in isolated rat adipocytes
  122. Pertussis toxin enhances the beta-adrenergic and blocks the alpha-adrenergic regulation of renin secretion in renal cortical slices
  123. Effect of pertussis toxin on water metabolism in the rat
  124. Guanine nucleotide-induced positive cooperativity in muscarinic-cholinergic antagonist binding
  125. Hormonal responsiveness of liver cells during the liver regeneration process induced by carbon tetrachloride administration
  126. Pertussis toxin and the heart
  127. Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products
  128. Differential effects of adrenergic agonists and phorbol esters on the α1-adrenoceptors of hepatocytes and aorta
  129. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity
  130. Pertussis toxin potentiates anesthesia-induced renin secretion
  131. Possible involvement of two mechanisms of signal transduction in α1-adrenergic action. Selective effect of cycloheximide
  132. Transmodulation, receptor phosphorylation and protein kinases
  133. α1-Adrenergic and M1-muscarinic actions and signal propagation
  134. Pertussis toxin catalyzes the ADP-ribosylation of two distinct peptides, 40 and 41 kDa, in rat fat cell membranes
  135. Effect of pertussis toxin on the adrenergic regulation of plasma renin activity
  136. Forskolin effects on the beta-adrenergic responsiveness of rat hepatocytes
  137. Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver
  138. Effects of adenosine on liver cell damage induced by carbon tetrachloride
  139. Metabolic effects and cyclic AMP levels produced by glucagon, (1-Nα-trinitrophenylhistidine,12-homoarginine)glucagon and forskolin in isolated rat hepatocytes
  140. Effect of pertussis toxin on α2 -adrenoceptors: decreased formation of the high-affinity state for agonists
  141. Pertussis toxin blocks the action of morphine, norepinephrine and clonidine on isolated guinea-pig ileum
  142. Activation of lipolysis and cyclic AMP accumulation in rabbit adipocytes by isoproterenol in the presence of forskolin or pertussis toxin
  143. RX781094 a potent and selective α2-adrenergic antagonist. Effects in adipocytes and hepatocytes
  144. Direct action of pertussis toxin in isolated hamster fat cells
  145. Phorbol esters inhibit alpha1 adrenergic stimulation of glycogenolysis in isolated rat hepatocytes
  146. Modulation by thyroid status of cyclic AMP-dependent and Ca2+-dependent mechanisms of hormone action in rat liver cells
  147. Adrenergic regulation of ureogenesis in hepatocytes from adrenalectomized rats
  148. Effect of insulin on alpha1-adrenergic actions in hepatocytes from euthyroid and hypothyroid rats
  149. Pertussis toxin induces tachycardia and impairs the increase in blood pressure produced by alpha2-adrenergic agonists
  150. Effect of pertussis toxin on the hormonal regulation of cyclic AMP levels in hamster fat cells
  151. Pertussis toxin reverses Gpp(NH)p inhibition of basal and forskolin activated adipocyte adenylate cyclase
  152. Inositol administration restores the sensitivity of liver cells formed during liver regeneration to alpha1-adrenergic amines, vasopressin and angiotensin II
  153. Roles of alpha1- and beta-adrenergic receptors in adrenergic responsiveness of liver cells formed after partial hepatectomy
  154. Sensitivity of liver cells formed after partial hepatectomy to glucagon, vasopressin and angiotensin II
  155. Effect of pertussis toxin on hormonal responsiveness of rat hepatocytes
  156. H1-histaminergic activation stimulates phosphatidylinositol labeling in rabbit aorta
  157. Hypothyroidism abolishes the glycogenolytic effect of vasopressin, angiotensin II and A23187 but not that of α1 -adrenergic amines in rat hepatocytes
  158. Bordetella pertussis toxin and adenylate cyclase
  159. α1-Adrenergic action: only calcium?
  160. Characterization of the α1-adrenoceptors of rat white fat cells
  161. Vasopressin and angiotensin II stimulate ureogenesis through increased mitochondrial citrulline production.
  162. Effect of pertussis vaccine on α-adrenoceptors of the circulatory system of the rat
  163. Stimulation of ureogenesis through α1- and β-adrenoceptors in juvenile rat hepatocytes
  164. Angiotensin II inhibits the accumulation of cyclic AMP produced by glucagon but not its metabolic effects
  165. Cycloheximide: An adrenergic agent
  166. Regulation of adipose tissue metabolism by catecholamines: roles of alpha1, alpha2 and beta-adrenoceptors
  167. Two types of alpha adrenoceptors in liver cells
  168. Effect of thyroid status on α- and β-catecholamine responsiveness of hamster adipocytes
  169. Effects of pertussis vaccine on the lipid metabolism of hamsters
  170. α1-adrenoceptor activation stimulates ureogenesis in rat hepatocytes
  171. Decreased sensitivity to α2 adrenergic amines, adenosine and prostaglandins in white fat cells from hamsters treated with pertussis vaccine
  172. Alpha2 adrenergic amines, adenosine and prostaglandis inhibit lipolysis and cyclic AMP accumulation in hamster adipocytes in the absence of extracellular sodium.
  173. Alpha1-adrenergic activation of phosphatidylinositol labeling in isolated brown fat cells
  174. Role of alpha1 adrenoceptors in the turnover of phosphatidylinositol and of alpha2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes
  175. Effects of adenosine on ethanol-induced modifications of liver metabolism
  176. Role of phosphatidylinositol turnover in alpha1 and of adenylate cyclase inhibition in alpha2 effects of catecholamines
  177. Mechanism of the fatty liver induced by cycloheximide and its reversibility by adenosine
  178. On the mechanism of ethanol-induced fatty liver and its reversibility by adenosine
  179. Importance of the esterification process in adipose tissue metabolism as evidenced by cycloheximide
  180. Effect of ethanol and n-butanol on alloxan inhibition of glucose-induced insulin release in isolated pancreatic islets
  181. Lipogenic action of cycloheximide on the rat epididymal fat pad